Entries by hleonhardt

PressureStim a Leonhardt Ventures Co. Announces Licensing of Patent Portfolio for Bioelectric Blood Pressure Management from Neuro Code Tech Holdings LLC Expanding Its Intellectual Property Estate.

Press Release – Santa Monica, California and Albuquerque, New Mexico, September 22nd, 2017 – PressureStim, an emerging leader in bioelectric blood pressure management announced today that the Company has entered into an option agreement that leads to an exclusive license with Neuro Code Tech Holdings LLC for key pioneering patents in the field of bioelectric management […]

Leonhardt Ventures Announces Launch of DentaCell Accelerator

Playa Vista, CA and Salt Lake City, Utah (PRBUZZ), October 23rd, 2017 – Leonhardt Ventures is excited to announce a new accelerator program focused on transforming innovation in dentistry – The DentaCell Accelerator. The DentaCell Accelerator is committed to inviting the most promising and innovative entrepreneurs to Los Angeles, Petaluma or Salt Lake City to […]

First bioelectric cancer tumor therapy designed for early detection, personalized real time reading

Leading innovation and startup accelerator focused on regenerative medtech and regenerative economy innovations is expanding into Playa Vista, California following Cedars Sinai, Yahoo, Imax, Google, YouTube, Facebook, USC Institute of Creative Technologies + USC Center for Body Computing and Honest Co. into Los Angeles’ leading tech startup community. Los Angeles, Playa Vista  – September 27th, 2017–  Leonhardt’s Launchpads is […]

Leonhardt Startup CancerCell Expands IP Estate for Bioelectric Treatment of Cancer Tumors

Published: Oct 20, 2017 First bioelectric cancer tumor therapy designed for early detection, personalized real time reading, customized communication jamming, stopping cell division, starving blood supply, changing surface protein expression to trigger immunotherapy, customized real time inflammation management and then regenerating the affected organ after cancer tumor is eradicated Playa Vista, CA and Salt Lake […]

Second Heart Assist Launches Series of Preclinical Development Studies at Tufts Medical Center

Published: Oct 20, 2017 Early development testing of innovative circulatory assist device results show promise Boston, Mass. and Salt Lake City, Utah – October 19th, 2017 (PRBUZZ)– Second Heart Assist, Inc. today announced the first successful implant of its Second Heart Assist, Inc. Gen. I Circulatory Support Assist device, in relevant preclinical models performed at Tufts Medical Center, in Boston, Massachusetts by Dr. […]

Bioleonhardt And Second Heart Assist To Present At Intl. Academy Of Cardiology World Congress Of Heart Disease July 14th-16th Vancouver

Published: Jul 13, 2017 Santa Monica, CA and Salt Lake City, UT (PRBUZZ) July 12th, 2017  – Leonhardt’s Launchpads is pleased to announce a number its portfolio companies will be presenting at the upcoming International Academy of Cardiology World Congress of Heart Disease in Vancouver, Canada July 14th to 16th. BioLeonhardt has been selected to […]

Leonhardt Adds HIF-1 Alpha To Estate Of Bioelectric Controlled Release Regenerative Proteins

Published: Jun 13, 2017 Salt Lake City, Utah and Santa Monica, CA – June 8th, 2017 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration and recovery focused innovation/startup accelerator today announced that it has filed a new patent application claim for the controlled expression of Hypoxia Inducible Factor 1 (HIF 1 Alpha).  HIF 1 Alpha is a powerful organ regeneration protein. This patent will be sub-licensed […]

Leonhardt Announces Vibrational Energy Device For Preventing Blood Clots Provisional Patent Application and License Agreements

Press Release – Santa Monica, CA and Salt Lake City, UT, May 23, 2017 (PRBUZZ) — Leonhardt’s Launchpads announces today that the Company has filed a provisional patent application to expand its current intellectual property portfolio to now include a harmonic vibrational resonance energy device to prevent blood clots, plaque and calcification on blood contact […]